BioSpace News Archive

ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, announced initial safety and efficacy findings from its Phase 1b/2 study of IMGN632 in combination with Vidaza® and Venclexta® in patients with relapsed/refractory acute myeloid leukemia.

Rocket Pharmaceuticals, Inc., a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces upcoming data presentations at the 63rd American Society of Hematology Annual Meeting taking place virtually and in Atlanta, Georgia from December 11-14, 2021.

Ambu Inc., the world leader in single-use endoscopy, announced that an Ohio gastroenterologist has become the first physician in the U.S. to use Ambu’s new sterile, single-use duodenoscope in 100 endoscopic retrograde cholangiopancreatography procedures.

VolitionRx Limited, a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose and monitor a range of cancers and other life-altering diseases in both humans and animals, is presenting two abstracts at the 2021 Veterinary Cancer Society Virtual Annual Conference, which takes place from Thursday, November 4 through Saturday, November 6.

Keros Therapeutics, Inc. today announced that four abstracts will be presented at the 63rd American Society of Hematology (“ASH”) Annual Meeting and Exposition, to be held in person and virtually from December 11 through 14, 2021.

Keros Therapeutics, Inc. today provided a business update and reported financial results for the quarter ended September 30, 2021.

Editas Medicine, Inc., a leading genome editing company, announced that two scientific abstracts have been accepted for presentation at the 63rd Annual Meeting and Exposition of the American Society of Hematology, being held in Atlanta and virtually, December 11-14, 2021.

Mereo BioPharma Group plc announced that data from an investigator-sponsored study of alvelestat in patients with Bronchiolitis Obliterans Syndrome following hematopoietic stem cell transplantation will be shared in a poster presentation at the 2021 American Society of Hematology Annual Meeting, being held December 11-14, 2021 in Atlanta, Georgia and virtually.

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced a preclinical poster presentation at the American Society of Hematology Annual Meeting to be held December 11-14, 2021, in Atlanta, GA.

Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three and nine months ended September 30, 2021.